Risk factors for tuberculin skin test conversion among HIV-infected patients in New York City

International Journal of Infectious Diseases

Volumn 16, Issue 7, 2012, Pages

  Doshi, Saumil ^a,b   Chen, Tina Fang ^a   Zapata, Josue ^a,c   Holzman, Robert S ^a   Zapata, Luis C ^a   Aberg, Judith A ^a   Sivapalasingam, Sumathi ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EMORY UNIVERSITY HOSPITAL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Diagnosis; HIV; Latent tuberculosis infection; Tuberculin skin test

Indexed keywords

ADULT; AGED; ARTICLE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; MEDICAL DOCUMENTATION; RISK FACTOR; SEROCONVERSION; TUBERCULIN TEST; UNITED STATES; URBAN AREA;

ADULT; AGED; AIDS-RELATED OPPORTUNISTIC INFECTIONS; CD4 LYMPHOCYTE COUNT; FEMALE; HIV INFECTIONS; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NEW YORK CITY; RISK FACTORS; TUBERCULIN TEST; TUBERCULOSIS; YOUNG ADULT;

EID: 84862558372     PISSN: 12019712     EISSN: 18783511     Source Type: Journal    
DOI: 10.1016/j.ijid.2012.03.002     Document Type: Article

References (16)

1. Horsburgh C.R. Priorities for the treatment of latent tuberculosis infection in the United States. N Engl J Med 2004, 350:2060-2067.
2. Targeted tuberculin testing and treatment of latent tuberculosis infection. American Thoracic Society. MMWR Recomm Rep 2000, 49(RR-6):1-51. Centers for Disease Control and Prevention.
3. Measuring what matters: allocation, planning, and quality assessment for the Ryan White CARE Act 2004, Institute of Medicine, Institute of Medicine, Washington, DC.
4. French A.L., Evans C.T., Anastos K., Greenblatt R.M., Hershow R., Huebner R., et al. Incidence of tuberculin skin test conversion among HIV-infected and -uninfected women: results of a 6-year study. J Acquir Immune Defic Syndr 2006, 42:592-596.
5. Centers for Disease Control and Prevention. Reported tuberculosis in the United States, 2006. Atlanta, GA: US Department of Health and Human Services; 2007. Available at: (accessed July 2, 2011). http://www.cdc.gov/tb/statistics/reports/surv2006/default.htm.
6. Cain K.P., Benoit S.R., Winston C.A., MacKenzie W.R. Tuberculosis among foreign-born persons in the United States. JAMA 2008, 300:405-412.
7. Chan P.C., Chang L.Y., Wu Y.C., Lu C.Y., Kuo H.S., Lee C.Y., et al. Age-specific cut-offs for the tuberculin skin test to detect latent tuberculosis in BCG-vaccinated children. Int J Tuberc Lung Dis 2008, 12:1401-1406.
8. Nolan C.M., Elarth A.M., Barr H., Saeed A.M., Risser D.R. An outbreak of tuberculosis in a shelter for homeless men. A description of its evolution and control. Am Rev Respir Dis 1991, 143:257-261.
9. Schluger N.W., Huberman R., Holzman R., Rom W.N., Cohen D.I. Screening for infection and disease as a tuberculosis control measure among indigents in New York City, 1994-1997. Int J Tuberc Lung Dis 1999, 3:281-286.
10. Schluger N.W., Perez D., Liu Y.M. Reconstitution of immune responses to tuberculosis in patients with HIV infection who receive antiretroviral therapy. Chest 2002, 122:597-602.
11. Kaplan J.E., Masur H., Holmes K.K. Guidelines for preventing opportunistic infections among HIV-infected persons-2002. Recommendations of the US Public Health Service and the Infectious Diseases Society of America. MMWR Recomm Rep 2002, 51(RR-8):1-52.
12. Kendig E.L., Kirkpatrick B.V., Carter W.H., Hill F.A., Caldwell K., Entwistle M. Underreading of the tuberculin skin test reaction. Chest 1998, 113:1175-1177.
13. Barkan S.E., Melnick S.L., Preston-Martin S., Weber K., Kalish L.A., Miotti P., et al. The Women's Interagency HIV Study. WIHS Collaborative Study Group. Epidemiology 1998, 9:117-125.
14. Menzies D. Interpretation of repeated tuberculin tests. Boosting, conversion, and reversion. Am J Respir Crit Care Med 1999, 159:15-21.
15. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999. This is a Joint Statement of the American Thoracic Society (ATS) and the Centers for Disease Control and Prevention (CDC). This statement was endorsed by the Council of the Infectious Diseases Society of America. (IDSA), September 1999, and the sections of this statement. Am J Respir Crit Care Med 2000, 161(4 Pt 2):S221-S247. Targeted tuberculin testing and treatment of latent tuberculosis infection.
16. Centers for Disease Control and Prevention. Cases of HIV infection and AIDS in urban and rural areas of the United States, 2006. HIV/AIDS Surveillance Report 2008. Atlanta, GA: US Department of Health and Human Services; 2008. Available at: (accessed April 18, 2012). http://www.cdc.gov/hiv/topics/surveillance/resources/reports/2008supp_vol13no2/.